Immunobiochemical profile of clear cell renal cell carcinoma (ccRCC): A preliminary study

被引:2
|
作者
Vargova, Daniela [1 ,6 ]
Dargaj, Jan [2 ,3 ]
Franova, Sona [1 ]
Dohal, Matus [4 ]
Luptak, Jan [2 ,3 ]
Svihra, Jan [2 ,3 ]
Bris, Lukas [2 ,3 ]
Grendar, Marian [5 ]
Sutovska, Martina [1 ]
机构
[1] Comenius Univ, Jessenius Fac Med Martin, Dept Pharmacol, Martin, Slovakia
[2] Comenius Univ, Jessenius Fac Med Martin, Dept Urol, Bratislava, Slovakia
[3] Univ Hosp Martin, Martin, Slovakia
[4] Comenius Univ, Jessenius Fac Med Martin, Biomed Ctr Martin, Martin, Slovakia
[5] Comenius Univ, Jessenius Fac Med Martin, Biomed Ctr Martin, Bioinformat Unit, Martin, Slovakia
[6] Comenius Univ, Jessenius Fac Med, Dept Pharmacol, Martin, Slovakia
关键词
Renal cell carcinoma; Cytokines; STAT3; Tumor; Immune system; ENDOTHELIAL GROWTH-FACTOR; PROTEIN; 10; IP-10; GM-CSF; GENE-EXPRESSION; CANCER; STAT3; SURVIVAL; ACTIVATION; CHEMOKINES; APOPTOSIS;
D O I
10.4149/gpb_2023015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Clear cell renal cell carcinoma (ccRCC) is the most common variant of RCC. It is an aggressive disease with an unfavorable prognosis. The rich immune infiltrates present in the tumor microenvironment (TME) of ccRCC produce various signaling molecules, especially cytokines, which primarily activate the Jak/STAT pathway and significantly influence tumor pathogenesis. STAT3 has a well-defined oncogenic character. Using multiplex assays and ELISA, we have measured the concentrations of 27 cytokines and STAT3 in tumor and healthy renal tissue from 16 patients with histologically verified ccRCC. We have detected significantly higher levels of G-CSF, IL-6, CXCL10, CCL3, and CCL4 in tumor tissue than in their healthy counterparts. There were significant differences in the levels of IL-1 beta and PDGF-BB between tumors of different nuclear grades (NG). Intra-tumoral IL-12p70 and IL-15 showed a significant positive correlation with intratumoral STAT3. The concentration of STAT3 in tumors was significantly lower than in the kidney. An increase in tumor STAT3 levels was associated with an increase in the pathological stage of the disease (TNM), but not with NG. The results of our study confirm the significant role of various cytokines and STAT3 in the pathogenesis of ccRCC and indicate their clinical relevance.
引用
收藏
页码:387 / +
页数:16
相关论文
共 50 条
  • [31] Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)
    Bielecka, Zofia F.
    Czarnecka, Anna M.
    Solarek, Wojciech
    Kornakiewicz, Anna
    Szczylik, Cezary
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2013, 8 (03) : 219 - 228
  • [32] Identification of prognostic genomic markers in patients with localized clear cell renal cell carcinoma (ccRCC)
    Rini, B. I.
    Zhou, M.
    Aydin, H.
    Elson, P.
    Maddala, T.
    Knezevic, D.
    Parodi, L.
    Bukowski, R. M.
    Novotny, W. F.
    Cowens, J. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Post nephrectomy metachronous testicular metastasis in a case of clear cell renal cell carcinoma (ccRCC)
    Ghorai, Rudra Prasad
    Kumar, Sanjay
    Aggarwal, Vaibhav
    Kaushal, Seema
    BMJ CASE REPORTS, 2024, 17 (09)
  • [34] Chemerin signaling presents a novel metabolic weakness in clear cell renal cell carcinoma (ccRCC)
    Wang, Dazhi
    CANCER RESEARCH, 2022, 82 (12)
  • [35] Renal tubular epithelial dysplasia in sporadic clear cell renal cell carcinoma (CCRCC) and CCRCC with associated Von Hippel Lindau (VHL) disease
    Frey, A. B.
    Nijwaji, C.
    Che, M.
    Sakr, W.
    Grignon, D.
    LABORATORY INVESTIGATION, 2007, 87 : 147A - 147A
  • [36] Renal tubular epithelial dysplasia in sporadic clear cell renal cell carcinoma (CCRCC) and CCRCC with associated Von Hippel Lindau (VHL) disease
    Frey, A. B.
    Nijwaji, C.
    Che, M.
    Sakr, W.
    Grignon, D.
    MODERN PATHOLOGY, 2007, 20 : 147A - 147A
  • [37] Genomic Meta-analysis of Clear-cell Renal Cell Carcinoma (ccRCC) Aggregating Tumors to Resolve the Complexity of ccRCC
    Gessner, Kathryn H.
    Kim, William Y.
    Zambrano, Ibardo A.
    EUROPEAN UROLOGY, 2022, 81 (04) : 362 - 363
  • [38] Results of a feasibility study of I-124 girentuximab in metastatic clear cell renal cell carcinoma (m ccRCC).
    Keefe, Stephen Michael
    Rosen, Mark Alan
    Robinson, Janelle
    McGibney, Karen
    Marshall, Amy
    Mamtani, Ronac
    Vaughn, David J.
    O'Dwyer, Peter J.
    Haas, Naomi B.
    Pryma, Daniel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [39] Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study
    Al-Danakh, Abdullah
    Safi, Mohammed
    Alradhi, Mohammed
    Chen, Qiwei
    Baldi, Salem
    Zhu, Xinqing
    Yang, Deyong
    CELLS, 2022, 11 (22)
  • [40] Analysis of dual energy spectral CT and pathological grading of clear cell renal cell carcinoma (ccRCC)
    Wei, Jinyan
    Zhao, Jianhong
    Zhang, Xueling
    Wang, Dan
    Zhang, Wenjuan
    Wang, Zhiping
    Zhou, Junlin
    PLOS ONE, 2018, 13 (05):